Related Experiment Video
Updated: Aug 30, 2026

An Experimental Model to Study Tuberculosis-Malaria Coinfection upon Natural Transmission of Mycobacterium tuberculosis and Plasmodium berghei
Published on: February 17, 2014
[Pulmonary anthrax]
1Service des maladies infectieuses et tropicales, Hôpital militaire Bégin, Saint Mandé.
Abstract:
Anthrax is a zoonotic disease caused by Bacillus anthracis. Skin disease is the most common form in humans. Pulmonary anthrax related to the inhalation of airborne germs develops after a silent incubation period of several days and followed by acute respiratory distress. Diagnosis is a difficult task and generally based on demonstration of Bacillus anthracis on direct examination. Despite the sensitivity of B. anthracis to penicillin, treatment is rarely successful.
Insights
Anthrax, a zoonotic disease caused by Bacillus anthracis, commonly presents as skin disease but can lead to severe pulmonary issues. Early diagnosis and treatment of anthrax remain challenging, often with limited success despite antibiotic sensitivity.
Area of Science:
- Infectious Diseases
- Microbiology
- Public Health
Background:
- Anthrax is a serious zoonotic disease caused by Bacillus anthracis.
- Skin anthrax is the most frequent human manifestation.
- Pulmonary anthrax, resulting from inhaling airborne Bacillus anthracis, presents insidiously with a prolonged incubation period followed by severe respiratory distress.
Purpose of the Study:
- To highlight the challenges in diagnosing and treating anthrax.
- To underscore the severity of pulmonary anthrax.
- To emphasize the limitations of current treatment protocols for Bacillus anthracis infections.
Main Methods:
- Review of clinical presentations of anthrax.
- Discussion of diagnostic challenges, focusing on direct examination for Bacillus anthracis.
- Analysis of treatment outcomes and antibiotic sensitivity.
Main Results:
- Diagnosis of anthrax is often difficult, relying on direct demonstration of Bacillus anthracis.
- Pulmonary anthrax has a high mortality rate due to delayed diagnosis and acute respiratory distress.
- Despite Bacillus anthracis's in vitro sensitivity to penicillin, clinical treatment success rates are frequently low.
Conclusions:
- Effective and timely diagnosis of anthrax is critical for improving patient outcomes.
- Pulmonary anthrax requires urgent medical intervention due to its rapid progression and severity.
- Further research into novel therapeutic strategies is needed to overcome treatment resistance in Bacillus anthracis infections.
Related Concept Videos
Other Pulmonary Disorders
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Inhalation Anthrax

